Vaxart, Inc. - Common Stock
看多

VXRT could rise

366
Even though VXRT is in the stabilization phase, it could continue to rise 20% to its next resistance of around $ 9.
Good news with possibilities in India and upcoming oral vaccine news.
OBV reveals that money is still coming in and has a positive slope.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。